rs143008696
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_014339.7(IL17RA):c.152C>T(p.Thr51Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00367 in 1,613,292 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014339.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL17RA | NM_014339.7 | c.152C>T | p.Thr51Met | missense_variant | 2/13 | ENST00000319363.11 | NP_055154.3 | |
IL17RA | NM_001289905.2 | c.152C>T | p.Thr51Met | missense_variant | 2/12 | NP_001276834.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL17RA | ENST00000319363.11 | c.152C>T | p.Thr51Met | missense_variant | 2/13 | 1 | NM_014339.7 | ENSP00000320936.6 |
Frequencies
GnomAD3 genomes AF: 0.00225 AC: 343AN: 152108Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00178 AC: 447AN: 251486Hom.: 0 AF XY: 0.00161 AC XY: 219AN XY: 135920
GnomAD4 exome AF: 0.00382 AC: 5580AN: 1461066Hom.: 10 Cov.: 30 AF XY: 0.00368 AC XY: 2678AN XY: 726894
GnomAD4 genome AF: 0.00225 AC: 343AN: 152226Hom.: 1 Cov.: 32 AF XY: 0.00216 AC XY: 161AN XY: 74424
ClinVar
Submissions by phenotype
Immunodeficiency 51 Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | IL17RA NM_014339.6 exon 2 p.Thr51Met (c.152C>T):This variant has not been reported in the literature but is present in 0.3% (409/129168) of European alleles including 1 homozygote, in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/22-17577965-C-T?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:340565). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
IL17RA-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 28, 2024 | The IL17RA c.152C>T variant is predicted to result in the amino acid substitution p.Thr51Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.32% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including one homozygous individual. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at